Daniel A. Rushing - Concepedia

Concepedia

Author

Daniel A. Rushing

Indiana University – Purdue University Indianapolis

Also Known As

D A Rushing, D Rushing, D. A. Rushing, D. Rushing, D.A. Rushing, DANIEL RUSHING, Daniel A Rushing, Daniel A. Rushing, Daniel Rushing, Delaney Rushing

60

Publications

2.5K

Citations

23

H-Index

55

Concepts

All Affiliations

Indiana University – Purdue University Indianapolis Sarcoma Alliance for Research through Collaboration University of Pennsylvania The University of Texas MD Anderson Cancer Center Dana-Farber Cancer Institute

DA

About

Daniel A. Rushing is an author at Indiana University – Purdue University Indianapolis specializing in medicine, oncology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	823
2	Health Sciences	8	8	397
3	Gastroenterology	2	2	275
4	Engineering	1	1	14
5	Biomedical Engineering	1	1	14

Daniel A. Rushing

×

32

Publications

2.5K

Citations

23

H-Index

	Year	Citations
Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma Lara E. Davis, Vanessa Bolejack, Christopher W. Ryan, Journal of Clinical Oncology	2019	251
Results of an International Randomized Phase III Trial of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus Versus Placebo to Control Metastatic Sarcomas in Patients After Benefit From Prior Chemotherapy George D. Demetri, Sant P. Chawla, Isabelle Ray‐Coquard, Journal of Clinical Oncology	2013	239
Doxorubicin clearance in the obese. Keith A. Rodvold, Daniel A. Rushing, Duane A. Tewksbury Journal of Clinical Oncology Bariatric SurgeryPharmacotherapyCaloric RestrictionObesity PreventionObesity	1988	210
Gastrointestinal stromal tumors: CT and MRI findings Kumaresan Sandrasegaran, Arumugam Rajesh, Daniel A. Rushing, European Radiology Abdominal ImagingGastroenterologyGastrointestinal Stromal TumorsGi TechniqueGastrointestinal Pathology	2005	205
Gastrointestinal Stromal Tumors: Clinical, Radiologic, and Pathologic Features Kumaresan Sandrasegaran, Arumugam Rajesh, Jonas Rydberg, American Journal of Roentgenology	2005	136
Pharmacokinetics and pharmacodynamics of doxorubicin in patients with small cell lung cancer Stephen C. Piscitelli, Keith A. Rodvold, Daniel A. Rushing, Clinical Pharmacology & Therapeutics Doxorubicinol ExposureImpaired Liver FunctionHepatologyMedicinePharmacology	1993	132
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor Scott M. Schuetze, Vanessa Bolejack, Edwin Choy, Cancer	2016	128
Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers Milan Radovich, Patrick J. Kiel, Stacy Marie Nance, Oncotarget	2016	107
SARC009: Phase 2 study of dasatinib in patients with previously treated, high‐grade, advanced sarcoma Scott M. Schuetze, J. Kyle Wathen, David R. Lucas, Cancer	2015	105
Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patients. H. Ian Robins, Daniel A. Rushing, M Kutz, Journal of Clinical Oncology	1997	99

Page 1